Bio

Julian Oakley is a Senior Managing Director of the Firm’s Strategic Advisory business. Mr. Oakley has over 25 years of experience acting as a trusted advisor to a wide range of UK and international clients on many notable M&A and capital markets transactions. Some of his recent transaction experience includes advising Mitie on its acquisition of Interserve, Consort Medical on its sale to Recipharm, Refinitiv on its acquisition by LSEG, Aggregated Micropower’s sale to Asterion, Takeda on its offer for Shire, Mereo on its acquisition of Oncomed, Airbus Group SE on the divestment of its Defence Electronics Unit to KKR & Co. LLP, Engro Corporation on the sale of Engro Foods to Friesland Campina, Towershare Inc. on its sale to edotco, Datamars on the sale of a material shareholding to CDPQ, Cable and Wireless Communications plc (CWC) on its acquisition by Liberty Global, and CWC on the acquisition of Columbus International and disposal of Monaco Telecom. Previous notable transactions include advising UCB SA on its acquisition of Schwarz Pharma AG, Smiths Group plc on the sale of its Aerospace division to GE and Amersham Plc on its sale also to GE. Mr. Oakley was previously a co-founder of Braveheart, which was acquired by Evercore Partners in December 2006. Prior to joining Evercore, Mr. Oakley was a Managing Director at JPMorgan Cazenove where he was Head of the Consumer, Retail and Healthcare team. Prior to that, Mr. Oakley was a Managing Director in JPMorgan’s European advisory practice. Mr. Oakley is a B.A. (Hons) from Durham University and is a member of the Institute of Chartered Accountants of England and Wales.